Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PhD, I will offer my opinion one more time since you keep asking, then let it go. It’s getting tiring. IMHO, two years ago CaverStem WAS ready to go as they saw it. In 2018 the trial was well on its way and the year of watching the 40 patients was far along, due to wrap up in a August if I remember correctly. All CMTH did was attend the AUA to test the waters. That immediately garnered the attention of 8 doctors if memory serves. That interest and a decent SS got the typical buzz in the OTC and the PPS started to move. Most of us were in by then and remember it well. It was an exiting time. The trial was not over and peer review was a long way off, but the doctors involved and the 8 interested doctors all saw the preliminary evidence that the treatment was relatively simple and very safe and very effective. Using your own stem cells is safe even to a layperson, so it was easy for the doctors to get interested.
The downside at the time was the Magellan separator needed was expensive and my DD tells me the insurance for stem cells treatments was not taking into effect these were not foreign stem cells, but your own, and is very expensive as well. That caused 3 of the doctors to not sign up.
The other doctors were targeting the fall of 2018, and IMHO, the buzz would have kept up the PPS. BUT, unknown to all of us (poor communications) it was all on hold for months as they switched to the 2.0 RanFac method.
That delay alone happened over the winter and killed the PPS to just above .01 where it was the previous year before the AUA.
Those remaining doctors all opened up in the spring, but the damage was already done. The buzz was gone. The OTC is fickle and it is super hard to get moving again. Revs were obviously low and notes had to be issued. That is what really started the decline in the PPS.
The next big thing IMHO was again, poor communication. Because CMTH knew the critics would debate the clinical trial was done with the Magellan separator and not the RanFac method that has a stronger stem cell concentration, they decided to delay the clinical paper further by adding the first 100 RanFac patients. Brilliant move in my mind, but it needed to be explained and It was not, and the critics made hay with the delays and doubt.
There is much more to the story, but those are the two main reason we are were we are IMHO. I think CMTH was ready to commercialize to a degree two years ago, and felt that if they picked up 8 doctors at a convention, they would pick up scores more easily, but it was very fluid and things changed as they went along. Not having the clinical paper was a deal breaker for many doctors.
I also think, and this is just a guess, knowing the paper would not be out for a long time since they added the 100 new patients, CMTH decided not to spend the money to PR happenings and just patiently wait for the paper. That strategy, if it was one, or at least that reality, puts us right where we are. A SS that spiraled out of control partly of their doing and partly due to the way the OTC works with MM’s and we now have a horrible PPS.
Can CMTH recover from those events? I think they can, but it will never be what it could have been, that’s obvious. I also think StemSpine is the big brother and the game changer. It is deep in its clinical trail and CMTH did say in late 2019 it is about ready to get the green light. We needed that news before the RS IMO but I still think it will happen sooner than later.
We have already seen three CaverStem offices open post Clinical Paper and I suspect many more are now willing to join since they have the paper they needed. And there is a clear business plan in the filings. Sell enough RanFac kits to make a profit. It’s CLEAR, it’s just not working yet. The only other way I can think of is to sell or license your patent to others. Is that what they are doing with AmnioStem?
Time will tell if they succeed. I will hold my shares like DD until 2025 if I have too. The science keeps me hooked.
This is all IMO, based on my own DD. I could be wildly off, but that is how I simply see it. One last time...... Scams and frauds don’t have patents, trademarks and clinical trials and medical professionals using the product. Struggling companies do. Let’s see if they can win their struggles.
Light reading for the weekend G, just in case you forgot how much work and how many years has gone into the patents.
https://patents.justia.com/assignee/creative-medical-technologies-inc
https://creativemedicaltechnology.com/us-patent-granted-for-caverstem-treatment-of-erectile-dysfunction-using-stem-cell-therapy/
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=20090311223&OS=20090311223&RS=20090311223
Apples to Cucumber, wow
And that has what bearing on the validity of the patents? I am totally lost on this one. Honestly.
JD, I will kick the football one time. You put your keen mind and intellect into this back when they lost the QB rating. You know it is not automatic that just because the PPS is currently above .01. I don’t recall the rules at this point, and will not waste my time looking them up, but anyone who wants to can see what CMTH has to do to get back to the QB rating. I only remember its far easier to get back on it than getting that rating the first time around. I am sure someone will post the process.
I also assume CMTH will file for reinstatement when they meet the requirements, but only management knows that.
I’ll save this one and come back to it when they update their websites. Just to be clear, you are saying CELZ is lying about those offices???
Gint, seeing THREE offices open up quickly on the heals of the Clinical Paper is very telling.
Yes, the PPS is horrible unless you are averaging down, but now that the procedure is CLINICALLY proven safe and effective and that more and more doctors are FINALLY starting to get on board, should show anyone looking with an open mind that the company is real and no fraud. The delay in issuing the paper after adding the 100 2.0 patients has proven costly, but doesn’t show wrongdoing.
Add to that, StemSpine is far along in their CLINICAL trial and much more will be know soon.
What is CMTH doing with AmnioStem?
Three. Don’t forget Dr. Gentry and Associates at Maverick Male Medical are now accepting patients throughout Arkansas.
If there is FRAUD, please explain one thing that meets the definition; Fraud - noun - wrongful or criminal deception intended to result in financial or personal gain.
There is nothing to support that conclusion IMO. The company business model has failed to date, nothing more, nothing less.
Several folks have reported the company to the AZ DA, to the SEC to the FBI and nothing has been found because there is nothing to be found IMO.
CELZ has not been commercially successful because they have not sold enough kits. IMO, that was due to the delays between CaverStem and CaverStem 2.0 and paper being extended a year to include the first 100 2.0 patients. It’s simple math, clear as the day is long.
As an example, if I open a restaurant and it is not successful and goes out of business, did I committed a fraud? Of course not. CELZ could go out of business too, who knows, but I see no FRAUD.
Companies fail all the time and many struggle before they succeed. That is what is happening here IMO. If CELZ was a fraud, they would have NO patents, NO trademarks, NO clinical trial paper, NO physicians etc. they would have pumped out tons of promising pressers and diluted as fast as possible. All CELZ has done is to start up way too slow, not have enough revs, and was forced to issues small notes for under $300k at a time every few months to stay alive. Those notes cost them severely as they death spiraled, and we all know fuel was added to the fire.
Someone show me one piece of EVIDENCE it is a FRAUD and I will listen. The long investors choose to remain optimistic for two reasons. One is the science. It is PROVEN and it will be successful. Investors are betting CELZ will be part of it. The other is my cash is riding on it. Why would I post negativity about own investment? That makes zero financial sense and seems counterintuitive.
Show me CELZ is a FRAUD and I will join the fight. In the meantime, I will wait and see how many doctors sign up now that the Clinical Review paper is out. We have seen two offices open already. When will they announce the buzz we know is brewing about StemSpine? Will they work out a deal on AmnioStem as they reported? Who knows, but I can look up the patents and know those are all for real. No scam, no fraud, just not successful yet. That is how I see it until proven otherwise.
So, you are saying that if anyone supports the company, it’s criminal?
I would say the exact opposite is suspect.
Sage advice
Logic tells ya that the inventor cannot be a reviewer. That would be the whole purpose of a peer review. If the inventors could review their own work, everything would work great on paper LOL.
Wolf, that’s your interpretation vs mine. StemSpine is in the final stages of studies on three continents IMO and will be much bigger than Caverstem. No link, so don’t ask please. And we all know CMTH has issued notes when necessary, just like any start up. Small ones every few months to pay the bills. Yes, they spiraled horribly based on the PPS and I hate the RS more than most, trust me. But, CMTH will have its day. CMTH has been working on all of this since 2011. They are on their time, not ours. Things easily could have continued up like they did in 2018. You and I both know what they didn’t. CELZ is boxed into the corner for sure, but not down yet.
Well said.
As I just opined elsewhere.... IMO, many have been waiting on the clinical trial. This could start taking off like a doublemint gum commercial. It should have happened last year, especially with the crack down on fat cell derived shady stem cell companies.
Yes, irrefutable.
Thanks weesnel, you beat me to it! Like I mentioned the other day, IMHO, many Doctors were waiting in the Clinical Trial data. We will see more and more coming on board.
02/03/2020 Close $0.031 volume 147,21. Open $0.0189 high $0.07 low $0.0124
Because of the science behind it all. It’s irrefutable.
Wolf, I didn’t say fascinating, I said interesting. Like we all have, I have been through a few RS, none ending well. I don’t recall any having a D added to the ticker for 20 days. I find that different and interesting. Probably means nothing.
Previous experiences were also that the company diluted heavy into the RS while we are all handcuffed for a day or so. Not seeing that either. Just interesting, looking for some thoughts, not ridicule.
Can trade now. All shares are converted.
TDA reconciled
Yes it would sir.
I still find this language interesting. This I have not seen before.
From the 8K
On the Effective Date, the Company’s trading symbol will change to “CELZD” for a period of 20 business days, after which the “D” will be removed from the trading symbol, which will revert to the original symbol of “CELZ”. In connection with the Reverse Stock Split, the CUSIP number for the Company’s Common Stock will change to 22529Y 200.
New Issues
The letter D can also indicate a new issue of stock. Seeking to raise capital, companies go to the public stock market to offer their shares. When company stocks (or bonds) appear on stock tables for the first time, the ticker symbol is followed by the letter D. The symbol appears in the quotations issued by the exchange itself. A brokerage quotation, or a quotation appearing in the financial media, may not carry appended symbols. On average, the symbol remains for about 20 business days.
PhD, we haven’t been fed anything. We are starving mushrooms ;(
StihlSaw. All I have ever debated is that CELZ is clearly NOT a Scam, Fraud etc. Scams don’t have patents, trademarks, science based products, government run clinical trials, and doctors performing the procedures, etc. etc.
There has never been a pump, in fact, that is half the argument here....... the company is near silent.
As of now it is nothing more than an unsuccessful startup biotech company. They have failed to generate enough revs with their business model and the notes they used to stay afloat spiraled out of control......With a little help as you know.
I am down huge on CELZ and have nothing to do but hold and let it play out. I think the science will prevail sooner or later. Many others don’t and have moved on.
I think we will see doctors signing on much faster now that the clinical is out, just like TX. It may take a while before enough do, so I have no choice but to wait, do I?
What’s intriguing is that StemSpine and AmnioStem can change everything.
My Fidelity shares just reconciled, TDA have not.
It will all settle overnight I suspect. Last one I was in with TDA took a day or two to settle. I made a small buy today to test the waters. Tax guy is gonna hate me in a few years LOL
LOL. Who knows what notes are left or when Tim sells more of them. I don’t think the AS on OTCMarkets will hold. Didn’t CELZ say they were reducing to 1B. The 40M is just the converted ratio. But we can hope. It’s the OS we need to watch.
Still says 2.7B outstanding. They just canceled my old sell order, so they are processing slowly LOL
Just good timing
Me either. I just saw it on OTCMARKETS
https://www.otcmarkets.com/stock/CELZD/security
Nice and lean at least.
Authorized Shares
40,000,000
02/03/2020
Outstanding Shares
17,554,009
02/03/20
StihlSaw. All I have ever debated is that CELZ is clearly NOT a Scam, Fraud etc. Scams don’t have patents, trademarks, science based products, government run clinical trials, and doctors performing said procedures, etc.
As of now it is nothing more than an unsuccessful startup biotech company. They have failed to generate enough revs with their business model and the notes they used to stay afloat spiraled out of control......With a little help as you know.
I am down huge on CELZ and have nothing to do but hold and let it play out. I think the science will prevail sooner or later. Many others don’t and have moved on. You won’t find a post from me saying it’s a deal. The closest you will ever find is me saying the PPS sucks, unless you are buying. I did buy as low as .0003. I may again when the right news hits. The RS is ridiculous and could be the death sentence, only time will tell.
OK, but that has not been my experience.
It always takes a few days for the conversions for retail. What you have to look out for is the company selling through their MM, or note holders selling. That has not happened yet. And you won’t see the company dumping. They never have. It has always been the note holders and one other ;)
New Issues
The letter D can indicate a new issue of stock. Seeking to raise capital, companies go to the public stock market to offer their shares. When company stocks (or bonds) appear on stock tables for the first time, the ticker symbol is followed by the letter D. The symbol appears in the quotations issued by the exchange itself. A brokerage quotation, or a quotation appearing in the financial media, may not carry appended symbols. On average, the symbol remains for about 20 business days.